{% extends 'skin_app/base.html' %}
{% load static %}
{% block content%}
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f4f4f4;
        }

        h1.heading-3 {
            text-align: center; /* Center the h1 horizontally */
            width: 100%; /* Make the h1 full width */
        }


        .newsstand {
            display: flex;
            flex-wrap: wrap;
            justify-content: space-evenly;
            padding: 20px;
        }

        .news-card {
            background-color: #fff;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
            margin: 20px;
            overflow: hidden;
            width: 500px;
            transition: transform 0.3s;
        }

        .news-card:hover {
            transform: scale(1.05);
        }

        .news-image {
            width: 100%;
            height: 150px;
            object-fit: cover;
        }

        .news-content {
            padding: 20px;
        }

        .news-title {
            font-size: 1.5rem;
            font-weight: bold;
            margin-bottom: 10px;
            font-family: Montserrat, sans-serif;
        }

        .news-description {
            color: #555;
        }
    </style>
<body>
<br><br><br><br><br>
    <h1 class="heading-3">Newsstand</h1>
    <div class="newsstand">

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/150" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">Pretreatment testing rates for patients with skin diseases may diverge from guidelines</h2>
                <p class="news-description">Data showed that not all patients with chronic inflammatory skin diseases undergo pretreatment testing before initiating systemic immunomodulatory therapies, despite current guidelines, according to a study.</p>
            </div>
        </div>

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/151" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">Plant-based topical successfully targets both inflammation, bacteria in atopic dermatitis</h2>
                <p class="news-description">MIAMI BEACH, Fla. — Zabalafin, a nonsteroidal topical, demonstrated efficacy in reducing inflammation and bacteria on the skin of children and adults with atopic dermatitis, according to interim data presented in a poster at Masters of Pediatric Dermatology.</p>
            </div>
        </div>

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/150" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">Healthy teen awakens with lesions in early morning hours</h2>
                <p class="news-description">A healthy, adolescent boy is seen for recurrently awakening with pruritic, urticarial-like lesions between his upper thighs extending to his mid-thorax.</p>
            </div>
        </div>

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/151" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">When all else fails: Treating hyperhidrosis with endoscopic thoracic sympathectomy</h2>
                <p class="news-description">Endoscopic thoracic sympathectomy (ETS) is a procedure that is performed to correct hyperhidrosis by interrupting the transmission of nerve signals from the spinal column to the sweat glands.</p>
            </div>
        </div>

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/152" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">Almirall enters license agreement with Novo Nordisk to develop NN-8828 in dermatology</h2>
                <p class="news-description">Almirall has entered into an exclusive license agreement with Novo Nordisk to develop and commercialize NN-8828 for autoimmune and inflammatory dermatological diseases, according to a company press release.</p>
            </div>
        </div>

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/153" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">First patient dosed in phase 2a trial of AX-158 for psoriasis</h2>
                <p class="news-description">The first patient has been dosed in Artax Biopharma’s phase 2a trial evaluating the safety and biomarker responses of AX-158 in a first proof-of-mechanism trial in psoriasis, the company announced in a press release.</p>
            </div>
        </div>

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/150" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">Delgocitinib cream outperforms alitretinoin capsule in treating severe chronic hand eczema</h2>
                <p class="news-description">Delgocitinib cream demonstrated superiority to alitretinoin capsules in the treatment of severe chronic hand eczema, LEO Pharma announced in a press release.</p>
            </div>
        </div>

        <div class="news-card">
            <img class="news-image" src="https://placekitten.com/300/151" alt="News Image">
            <div class="news-content">
                <h2 class="news-title">Regular checks, gentle products recommended for aging skin</h2>
                <p class="news-description">MIAMI BEACH, Fla. — Xerosis can be a significant issue for patients as they age and dermatology practioners should both be aware and remain vigilant with whole body checks in older patients according to a poster presentation here.</p>
            </div>
        </div>

    </div>
</body>

{% endblock content %}